efavirenz/emtricitabine/tenofovir disoproxil fumarate / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 34 Diseases   9 Trials   9 Trials   673 News 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
efavirenz/emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
2011-004935-30: Study “before-after”: Adherence Evaluation to antiretroviral therapy administered in two different ways Studio ''before-after'' di valutazione dell'aderenza di due diverse modalita' di somministrazione della terapia antiretrovirale

Ongoing
4
400
Europe
Film-coated tablet, EPIVIR*FL 30CPR RIV 300MG, VIREAD*30CPR 245MG, ZIAGEN*6BLISTER 10CPR 300MG, SUSTIVA*30CPR RIV 600MG BLIST, RETROVIR*60CPR 300MG, TRUVADA*30CPR RIV 200MG/245MG, KIVEXA*BL 30CPR RIV 600MG+300M, COMBIVIR*60CPR RIV 150MG+300MG, ATRIPLA*30CPR RIV600+200+245MG
U.L.S.S. 9 DI TREVISO, studio no profit, farmaci a carico del SSN
HIV infection Infezione da HIV, HIV infection Infezione da HIV, Diseases [C] - Virus Diseases [C02]
 
 
2015-000274-35: clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged virological suppression. ENSAYO CLÍNICO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE DOS ESTRATEGIAS DE SIMPLIFICACIÓN BASADAS EN DOLUTEGRAVIR EN PACIENTES INFECTADOS POR VIH CON SUPRESIÓN VIROLÓGICA SOSTENIDA.

Ongoing
4
450
Europe
Lamivudine, Efavirenz, nevirapine, J05AX12, Coated tablet, Capsule, hard, Tablet, Prolonged-release tablet, Tivicay, Stribild, TRUVADA, KIVEXA, ZIAGEN, VIREAD, EMTRIVA, ATRIPLA, EVIPLERA, ISENTRESS, RAYATAZ, PREZISTA, KALETRA, NORVIR, INTELENCE, EDURANT, TRIUMEQ
Fundació Lluita contra la SIDA, Fundació Lluita contra la SIDA
Infection with human immunodeficiency virus (HIV). Infección por el virus de la inmunodeficiencia humana (VIH)., HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
2014-004297-42: Effect of changing one medication (Atripla) to another (Eviplera) on functions of the brain and emotions Het effect van wisselen van het ene medicijn (Atripla) naar het andere medicijn (Eviplera) op de functies van de hersenen en emoties

Ongoing
4
60
Europe
Film-coated tablet, Eviplera, Atripla
UMC Utrecht, Gilead Sciences
neurocognitive and emotional functioning in HIV positive men using antiretroviral therapy neurocognitief en emotioneel functioneren bij HIV positieve mannen die antiretrovirale therapie gebruiken, brain functions and emotions with people infected with HIV who use anti-HIV medication. functies van het brein en emoties bij mensen geïnfecteerd met HIV die anti-HIV medicijnen gebruiken., Not possible to specify
 
 
2010-022120-72: The impact of a new single therapy (Darunavir/ritonavir) on metabolism after successfully suppressing the virus with the normal treatment (Atripla) for HIV-1-infected patients (MIDAs).

Ongoing
4
70
Europe
Prezista, Norvir, Atripla, Prezista, Norvir, Atripla
Guy\'s & St. Thomas\' NHS Foundation Trust, Tibotec (a division of Janssen-Cilag Ltd)
HIV
 
 
2010-022202-41: ESTUDIO PILOTO DEL CAMBIO EN LA ACTIVIDADANTIRRETROVIRAL EN SISTEMA NERVIOSO CENTRAL TRAS LA SUSTITUCIÓN DE TDF/FTC/EFV POR ABC/3TC/MVC

Ongoing
4
15
Europe
CELSENTRI 150 mg comprimidos recubiertos con película, ATRIPLA 600 mg/245 mg comprimidos recubiertos con película, KIVEXA 600 mg/300 mg comprimidos recubiertos con película, CELSENTRI 150 mg comprimidos recubiertos con película, ATRIPLA 600 mg/245 mg comprimidos recubiertos con película, KIVEXA 600 mg/300 mg comprimidos recubiertos con película
Daniel Podzamczer
Virus de imunodeficiencia humana-1
 
 
2015-005297-37: Bone Evaluation in women over 40 who Switch from Truvada/NNRTI to Triumeq

Ongoing
4
90
Europe
Tenofovir, Lamivudine, Efavirenz, Nevirapine, Etravirine, Rilpivirine, Film-coated tablet, Tablet, Triumeq, Truvada, Atripla, Eviplera
King's College Hospital NHS Foundation Trust, ViiV Healthcare Ltd
Human Immunodeficiency Virus, People infected with Human Immunodeficiency Virus (HIV), Diseases [C] - Immune System Diseases [C20]
 
 
2014-002284-15: A study to assess changes in Central Nervous System (CNS) function where no obvious symptoms exist, when switching from Atripla to Eviplera switch in HIV infected patients

Not yet recruiting
4
40
Europe
Eviplera, Film-coated tablet, Eviplera
St Stephen's AIDS Trust, Gilead Sciences Ltd
HIV, HIV, Diseases [C] - Immune System Diseases [C20]
 
 
2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing
4
100
Europe
lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy
FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare
HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
2018-003880-79: Switch from Efavirenz / emtricitabine / tenofovir difumarate taken once a day or alternate day to Bictegravir / emtricitabine / tenofovir alafenamide in HIV+ patients with suppressed viral load. Passaggio da Efavirenz/emtricitabina/tenofovir difumarato assunto una volta al giorno o a giorni alterni a Bictegravir/emtricitabina/tenofovir alafenamide in pazienti HIV+ con carica virale soppressa.

Not yet recruiting
4
240
Europe
Biktarvy, [-], Film-coated tablet, Biktarvy
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE "LAZZARO SPALLANZANI", Gilead Sciences Inc.
HIV infection Infezione da HIV, HIV infection infezione da HIV, Diseases [C] - Virus Diseases [C02]
 
 
2018-004499-36: study to assess the changes in bone health after changing from a TDF based regimen to Bicetegravir-Tenofovir Alafenamide-Emtricitavine based treatment Estudio para evaluar los cambios en la salud ósea tras el paso de un régimen basado en TDF a uno basado en Bictegravir-Tenofovir Alafenamida-Emtricitavina

Not yet recruiting
4
60
Europe
Biktarvy, Stribild, EMEA/H/C/004449, Pastille, Tablet, Biktarvy, Atripla, Stribild, EVIPLERA, REZOLSTA, TRUVADA
Consorci Mar Parc de Salut de Barcelona, Consorci Mar Parc de Salut de Barcelona
Bone health (bone mineral density, microarchitecture and bone quality) in HIV individuals under antiretroviral treatment with tenofovir disoproxil fumarate (TDF) that change treatment to bictegravir-tenofovir alafenamide-emtricitavin (BIC) Salud ósea (densidad mineral ósea, microarquitectura y calidad ósea) en personas con VIH bajo tratamiento antirretroviral con tenofovir disoproxil fumarato (TDF) que cambia el tratamiento a bictegravir-tenofovir alafenamida-emtricitavina (BIC), bone health in persons with HIV treatment based on TDF that change the treatment to bictegravir-TAF salud ósea en personas con VIH y tratamiento antirretroviral con TDF que cambian el tratamiento a bictegravir-TAF, Diseases [C] - Virus Diseases [C02]
 
 
2011-004038-33: Evaluation of the efficacy and the safety of the use of Atripla in alternate days versus the standard dose in HIV-1 infected patients already treated with a successful standard regimen Valutazione dell'efficacia e della sicurezza dell'uso di Atripla a giorni alterni rispetto alla dose standard in pazienti con infezione da HIV-1 che stanno gia' effettuando un trattamento standard con successo

Ongoing
3
200
Europe
Tablet, ATRIPLA*30CPR RIV600+200+245MG
ISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI, Ministero della Salute
HIV-1 Infection Infezione da HIV-1, HIV Infection Infezione da HIV, Diseases [C] - Virus Diseases [C02]
 
 
2014-003419-12: Switch from Efavirenz/Atripla to Rilpivirine Switch da Efavirenz/Atripla a Rilpivirina

Ongoing
3
90
Europe
EVIPLERA, ATRIPLA, Capsule, hard, EVIPLERA, ATRIPLA
AZIENDA OSPEDALIERA SAN GERARDO, MONZA, ITALIA, Gilead Sciences Srl
HIV INFECTION INFEZIONE DA HIV, HIV HIV, Diseases [C] - Immune System Diseases [C20]
 
 
DRIVE-AHEAD, NCT02403674 / 2014-003382-17: Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)

Completed
3
734
NA
Doravirine, Tenofovir, Lamivudine, MK-1439A, ATRIPLA™, Placebo
Merck Sharp & Dohme LLC
Human Immunodeficiency Virus (HIV)
03/17
09/23
MK-1439A-028, NCT02652260 / 2015-003617-18: Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants

Completed
2
86
NA
Doravirine, Tenofovir, Lamivudine - Blinded, MK-1439A, Doravirine, Tenofovir, Lamivudine - Open-Label, ATRIPLA^TM, Placebo to ATRIPLA™, Placebo to Doravirine, Tenofovir, Lamivudine
Merck Sharp & Dohme LLC
HIV-1, Central Nervous System
08/18
02/24

Download Options